Literature DB >> 18333258

The role of liver resections for metastases from lung carcinoma.

Giorgio Ercolani1, Matteo Ravaioli, Gian Luca Grazi, Matteo Cescon, Giovanni Varotti, Massimo Del Gaudio, Gaetano Vetrone, Matteo Zanello, Alfonso Principe, Antonio Daniele Pinna.   

Abstract

Liver resections are usually considered the treatment of choice for colorectal and neuroendocrine metastases. Recently, the morbidity and mortality rates for liver surgery have dramatically decreased. Therefore, hepatic resection has been applied in selected cases of non-colorectal, non-neuroendocrine hepatic metastases. We report our experience with three cases of liver metastases from lung carcinoma and review the literature, to evaluate the role of liver surgery for this indication.

Entities:  

Year:  2006        PMID： 18333258      PMCID： PMC2131419          DOI： 10.1080/13651820500471970

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN： 1365-182X            Impact factor:   3.647


  10 in total

Review 1.  Treatment of colorectal liver metastases.

Authors:  J G Geoghegan; J Scheele
Journal:  Br J Surg       Date:  1999-02       Impact factor: 6.939

Review 2.  Liver metastases from lung cancer: is surgical resection justified?

Authors:  Isidoro Di Carlo; Giuseppe Grasso; Domenico Patane'; Domenico Russello; Ferdinando Latteri
Journal:  Ann Thorac Surg       Date:  2003-07       Impact factor: 4.330

3.  Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results.

Authors:  M Minagawa; M Makuuchi; G Torzilli; T Takayama; S Kawasaki; T Kosuge; J Yamamoto; H Imamura
Journal:  Ann Surg       Date:  2000-04       Impact factor: 12.969

4.  The role of liver resections for noncolorectal, nonneuroendocrine metastases: experience with 142 observed cases.

Authors:  Giorgio Ercolani; Gian Luca Grazi; Matteo Ravaioli; Giovanni Ramacciato; Matteo Cescon; Giovanni Varotti; Massimo Del Gaudio; Gaetano Vetrone; Antonio Daniele Pinna
Journal:  Ann Surg Oncol       Date:  2005-05-05       Impact factor: 5.344

5.  Highly aggressive policy of hepatic resections for neuroendocrine liver metastases.

Authors:  G L Grazi; M Cescon; F Pierangeli; G Ercolani; A Gardini; A Cavallari; A Mazziotti
Journal:  Hepatogastroenterology       Date:  2000 Mar-Apr

6.  Cytoreductive hepatic surgery for neuroendocrine tumors.

Authors:  G P McEntee; D M Nagorney; L K Kvols; C G Moertel; C S Grant
Journal:  Surgery       Date:  1990-12       Impact factor: 3.982

7.  Liver resection of noncolorectal secondaries.

Authors:  G Lindell; B Ohlsson; A Saarela; R Andersson; K G Tranberg
Journal:  J Surg Oncol       Date:  1998-10       Impact factor: 3.454

8.  Liver resection for multiple colorectal metastases: influence of parenchymal involvement and total tumor volume, vs number or location, on long-term survival.

Authors:  Giorgio Ercolani; Gian Luca Grazi; Matteo Ravaioli; Matteo Cescon; Andrea Gardini; Giovanni Varotti; Massimo Del Gaudio; Bruno Nardo; Antonino Cavallari
Journal:  Arch Surg       Date:  2002-10

9.  Results of surgical resection of liver metastases from non-colorectal primaries.

Authors:  T Berney; G Mentha; A D Roth; P Morel
Journal:  Br J Surg       Date:  1998-10       Impact factor: 6.939

Review 10.  Hepatic resection for noncolorectal nonneuroendocrine metastases.

Authors:  S I Schwartz
Journal:  World J Surg       Date:  1995 Jan-Feb       Impact factor: 3.352
  10 in total
  2 in total

1.  Surgery for isolated liver metastases from pancreatic cancer.

Authors:  Nicola Zanini; Raffaele Lombardi; Michele Masetti; Marco Giordano; Giovanni Landolfo; Elio Jovine
Journal:  Updates Surg       Date:  2015-02-22

2.  Hepatectomy for oligo-recurrence of non-small cell lung cancer in the liver.

Authors:  Fumitaka Ishige; Wataru Takayama; Satoshi Chiba; Isamu Hoshino; Hidehito Arimitsu; Hiroo Yanagibashi; Yosuke Iwatate
Journal:  Int J Clin Oncol       Date:  2018-03-06       Impact factor: 3.402
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.